Appointment booking for Dr. Patrick Chang, MD is currently not available.Dr. Patrick Chang, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Patrick Chang, MD is a Internist in Chandler, AZ with over 18 years of experience. What is your opinion of Dr. Patrick Chang, MD? Rate this provider below so other people can make informed decision.
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Patrick Chang, MD has received over $4,469 which includes payments from the following companies:
$585.81 from GlaxoSmithKline, LLC.
$585.40 from Novo Nordisk Inc
$554.63 from sanofi-aventis U.S. LLC
$542.47 from AstraZeneca Pharmaceuticals LP
$412.65 from Janssen Pharmaceuticals, Inc
$327.74 from LILLY USA, LLC
$245.70 from Astellas Pharma US Inc
$167.71 from Amgen Inc.
$155.22 from Boehringer Ingelheim Pharmaceuticals, Inc.
$100.00 from COMSORT, Inc
$87.37 from BIOTRONIK INC.
$84.55 from Takeda Pharmaceuticals America, Inc.
$76.40 from Pfizer Inc.
$70.53 from AbbVie, Inc.
$44.61 from Merck Sharp & Dohme Corporation
$42.56 from Daiichi Sankyo Inc.
$40.92 from Boston Scientific Corporation
$35.93 from Sandoz Inc.
$34.99 from Auxilium Pharmaceuticals, Inc.
$32.48 from Abbott Laboratories
Payments received by Dr. Patrick Chang, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!